C-reactive protein and lipids may respond differently to statins

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.

European heart journal·2022

Advancing Beyond Failed High-density Lipoprotein Clinical Trials to Pharmacogenetic Studies of ADCY9 and Cholesterol Ester Transfer Protein Inhibition.

Journal of cardiovascular pharmacology·2021

Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.

Circulation. Genomic and precision medicine·2021

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease.

Diabetes care·2020

Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib.

American heart journal·2020

Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial.

American heart journal·2020

Novel Lipoprotein (a) Therapies: A Comprehensive Review.

Current atherosclerosis reports·2026

Exercise and Cardiovascular Risk Modulation in Post-COVID Syndrome.

Current atherosclerosis reports·2026

Finerenone in Heart Failure with Preserved Ejection Fraction: Expanding the Role of Non-steroidal Mineralocorticoid Receptor Antagonists.

Current atherosclerosis reports·2026

Dietary Interventions for Hypertriglyceridemia.

Current atherosclerosis reports·2026

Exercise Training and Heart Rate Variability: A Guided Optimization of Cardiorespiratory Fitness in Cardiometabolic Disease.

Current atherosclerosis reports·2026

Sphingolipids and Atherosclerosis.

Current atherosclerosis reports·2026

Splenic Steatopathy: A Clinical and Experimental Framework for Lipid-Associated Splenic Pathology.

Clinical and experimental gastroenterology·2026

Metabolomic profiling of HepG2/C3A liver-on-chip model exposed to oleic acid, palmitic acid and oleic/palmitic acids mixture.

NAM journal·2026

Extracellular vesicle lipidomics for disease diagnostics and mechanism-informed discovery.

Current opinion in biotechnology·2026

Ganoderma applanatum Polysaccharides in Obesity-Associated Dysglycaemia and Liver Injury: Gut-Liver Mechanisms and Translational Gaps.

Nigerian medical journal : journal of the Nigeria Medical Association·2026

Reversible Subacute Liver Failure Following Revisional Malabsorptive Bariatric Surgery: A Case Report.

Cureus·2026

Discriminative performance of non-invasive scoring systems for VCTE-defined steatosis and fibrosis in patients with psoriasis.

Hepatology forum·2026

Related Experiment Videos

C-reactive protein and lipids may respond differently to statins

Related Concept Videos

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.

Advancing Beyond Failed High-density Lipoprotein Clinical Trials to Pharmacogenetic Studies of ADCY9 and Cholesterol Ester Transfer Protein Inhibition.

Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease.

Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib.

Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial.

Novel Lipoprotein (a) Therapies: A Comprehensive Review.

Exercise and Cardiovascular Risk Modulation in Post-COVID Syndrome.

Finerenone in Heart Failure with Preserved Ejection Fraction: Expanding the Role of Non-steroidal Mineralocorticoid Receptor Antagonists.

Dietary Interventions for Hypertriglyceridemia.

Exercise Training and Heart Rate Variability: A Guided Optimization of Cardiorespiratory Fitness in Cardiometabolic Disease.

Sphingolipids and Atherosclerosis.

Splenic Steatopathy: A Clinical and Experimental Framework for Lipid-Associated Splenic Pathology.

Metabolomic profiling of HepG2/C3A liver-on-chip model exposed to oleic acid, palmitic acid and oleic/palmitic acids mixture.

Extracellular vesicle lipidomics for disease diagnostics and mechanism-informed discovery.

Ganoderma applanatum Polysaccharides in Obesity-Associated Dysglycaemia and Liver Injury: Gut-Liver Mechanisms and Translational Gaps.

Reversible Subacute Liver Failure Following Revisional Malabsorptive Bariatric Surgery: A Case Report.

Discriminative performance of non-invasive scoring systems for VCTE-defined steatosis and fibrosis in patients with psoriasis.

Related Experiment Videos

C-reactive protein and lipids may respond differently to statins

Related Concept Videos

Related Articles